✦ LIBER ✦

A phase II trial of low-dose docetaxel (DCT) 60 mg/m2 in platinum-pretreated advanced non-small cell lung cancer (NSCLC)

✍ Scribed by Kusaba, H; Nakamura, Y; Kunitoh, H; Sekine, I; Kubota, K; Tamura, T; Shinkai, T; Yamamoto, N; Ohe, Y; Kodama, T; Saijo, N

Book ID: 118569622
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 120 KB
Volume: 29
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(00)80077-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

147 Phase II studies of a 60 mg/m2 dose

147 Phase II studies of a 60 mg/m2 dose of docetaxel in patients with non-small cell lung cancer

✍ Hiraki, S.; Watanabe, K.; Furuse, K.; Kudo, S.; Ohnoshi, T.; Niitani, H. 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Phase I/II trial of gemcitabine plus doc

Phase I/II trial of gemcitabine plus docetaxel in advanced non small cell lung cancer (NSCLC)

✍ Valerie Israel; Scott T. Tagawa; Terry Snyder; Susan Jeffers; Derek Raghavan 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 66 KB

A phase I trial of cisplatin (CDDP), doc

A phase I trial of cisplatin (CDDP), docetaxel (DCT) and ifosfamide (IFX) in advanced non-small cell lung cancer (NSCLC)

✍ Kunitoh, H; Sawada, M; Watanabe, H; Akiyama, Y; Kusaba, H; Yamamoto, N; Sekine, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Phase II trial of a 75-mg/m2 dose of doc

Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer

✍ Vincent A. Miller; James R. Rigas; Prudence A. Francis; Stefan C. Grant; Katheri 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 493 KB 👁 2 views

## Background. A prior Phase I1 study of a 100-mg/m2 dose of docetaxel conducted at the Memorial Sloan-Kettering Cancer Center (New York, NY) demonstrated a 38% response rate with grade 3 or 4 neutropenia in 76% of the patients and a grade 2 or greater rash or infusionrelated reaction in 41% and 3

Phase II trial of a 75-mg/m2 dose of doc

Phase II trial of a 75-mg/m2 dose of docetaxel with prednisone premedication for patients with advanced non-small cell lung cancer

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 290 KB

Japanese experience with second-line che

Japanese experience with second-line chemotherapy with low-dose (60 mg/m2) docetaxel in patients with advanced non-small-cell lung cancer

✍ Toru Mukohara; Koji Takeda; Masaki Miyazaki; Nobuhide Takifuji; Kazuhiko Terakaw 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 79 KB